Cancer Research · 2016 · 36 citations · 25 references
MedicineImmunologyOncologyCancer ImmunologyImmunotherapyTumor ImmunologyAntitumor T Cell ResponsesCancer ImmunotherapyCancer VaccinesDendritic Cell BiologyTumor Immune MicroenvironmentTumor Microenvironment ModulationAntitumor Immune MemoryCancer Mrna VaccinesCancer Vaccine T-cell ResponsesDendritic Cell TargetingDendritic Cell-t Cell InteractionTertiary Lymphoid StructuresTumor Vasculature NormalizationTumor-specific T Cell Clones
Strategies to reprogram the tumor microenvironment are being explored to improve cancer immunotherapy. In one approach, we have targeted dendritic cells (DC) to improve their function with adjuvant vector cells (aAVC) that are engineered from NKT ligand-loaded CD1d(+) allogeneic cells transfected with tumor antigen mRNAs. Here, we report the finding that this approach also programs local immune responses by establishing tertiary lymphoid structures (TLS), which include expanded antigen-specific CD8(+) T-cell clones, mobilized DCs, and normalized tumor vasculature. aAVC therapy also expanded specific Vβ-expressing antitumor T-cell clones, leading to the formation of long-term memory T cells. When combined with PD-1 blockade, aAVC infusion triggered regression of poorly immunogenic tumor cells that did not respond to PD-1 blockade alone, as well as expansion of antigen-specific CD8(+) T-cell clones in the tumor. The findings of this study help to inform a next-generation platform for the generation of efficacious cancer vaccines. Cancer Res; 76(13); 3756-66. ©2016 AACR.
25
Effector Memory T Cells, Early Metastasis, and Survival in Colorectal Cancer
Franck Pagès, Anne Berger, Matthieu Camus et al. · New England Journal of Medicine · 2005 · 2.1K citations · Full text
Medicine, Immunology, Oncology +17
Paul F. Robbins, Richard A. Morgan, Steven A. Feldman et al. · Journal of Clinical Oncology · 2011 · 1.6K citations · Full text
Life Sciences, Immunology, Oncology +17